Company Tagline
Pioneering thymus-empowered T-cell platform to fight cancer and infection
Industry Category
Business Keywords
Company Description
Smart Immune is a cutting-edge biotechnology research company dedicated to revolutionizing the treatment of cancer and infection. Located at Paris Biotech santé - Pole innovation 29, Rue du Faubourg Saint-Jacques, Paris, Île-de-France 75014, FR, Smart Immune is pioneering the development of ProTcell, an innovative thymus-empowered T cell progenitor platform. This technology is designed to rapidly and completely re-arm the immune system, paving the way for next-generation allogeneic T cell therapies.
With a focus on hematology and immune-oncology, Smart Immune is committed to significantly improving patient outcomes. The company’s SMART101 is currently in Phase I/II clinical trials, targeting cancer patients with AML and ALL, as well as SCID in both the EU and the US. Furthermore, Smart Immune is actively developing gene-modified T cell progenitor therapies through its ProTcell platform to deliver targeted treatments such as off-the-shelf CAR T-cell therapies. Smart Immune maintains strong collaborations with leading institutions across the US and Europe to further its research and development efforts.
Smart Immune is dedicated to innovation and excellence in biotechnology. The company's management team is actively working to provide more detailed information about its groundbreaking work, which will be available soon. We invite the management team at Smart Immune to create a customized and exclusive company showcase and product listing on our platform to further highlight their contributions to the field. Smart Immune is setting new standards in immune-oncology and beyond.
Smart Immune est une entreprise de recherche biotechnologique de pointe dédiée à révolutionner le traitement du cancer et des infections. Située à Paris Biotech santé - Pôle innovation 29, Rue du Faubourg Saint-Jacques, Paris, Île-de-France 75014, FR, Smart Immune est pionnière dans le développement de ProTcell, une plateforme innovante de progéniteurs de lymphocytes T activée par le thymus. Cette technologie est conçue pour réarmer rapidement et complètement le système immunitaire, ouvrant la voie à des thérapies allogéniques de lymphocytes T de nouvelle génération.
Avec un accent sur l'hématologie et l'immuno-oncologie, Smart Immune s'engage à améliorer considérablement les résultats pour les patients. Le SMART101 de la société est actuellement en essais cliniques de phase I/II, ciblant les patients atteints de cancer avec LAM et LAL, ainsi que le DICS dans l'UE et aux États-Unis. De plus, Smart Immune développe activement des thérapies de progéniteurs de lymphocytes T génétiquement modifiés via sa plateforme ProTcell pour fournir des traitements ciblés tels que les thérapies CAR-T prêtes à l'emploi. Smart Immune entretient de solides collaborations avec des institutions de premier plan aux États-Unis et en Europe pour faire avancer ses efforts de recherche et développement.
Smart Immune se consacre à l'innovation et à l'excellence dans la biotechnologie. L'équipe de direction de la société travaille activement à fournir des informations plus détaillées sur son travail novateur, qui seront bientôt disponibles. Nous invitons l'équipe de direction de Smart Immune à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin de mettre davantage en évidence leurs contributions au domaine. Smart Immune établit de nouvelles normes en immuno-oncologie et au-delà.
Key Personnel / Employees
Compare Companies Side by Side
Compare Smart Immune with 3 companies in Biotechnology-Research
| Comparison Field |
Smart ImmuneMain Company |
BioNTech SEView Profile |
Morgan Prestwich - L...View Profile |
Skin2NeuronView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2008 | 2010 | 2019 |
|
Company Size
|
— | 1,001-5,000 | 11-50 | 2-10 |
|
City
|
Paris, Île-de-France | Mainz, Rhineland-Palatinate | Reigate, Surrey | Sydney, New South Wales |
|
Country
|
France | Germany | United Kingdom | Australia |
|
Skills & Keywords
Comparing with main company
|
16 Total Skills
Biotechnology
T cell therapy
Immuno-oncology
Cell therapy
CAR T-cell therapies
Hematology
ProTcell platform
T cell progenitors
NK cells
HSC differentiation
Lymphoid progenitors
T cells
Immune reconstitution
Thymic selection
Naive cells
CAR T
|
12 Total
12 Unique
Unique Skills:
Antibody therapeutics
Bispecific antibodies
Immunotherapy
Individualized cancer medicine
Infectious diseases
mRNA therapeutics
+6
|
54 Total
54 Unique
Unique Skills:
Biotech
Biotech Recruitment
Biotechnology Recruitment
Boards
Business Development
Cell Therapy
+48
|
4 Total
4 Unique
Unique Skills:
Alzheimer's disease
Medical Research
Regenerative Medicine
Stem Cells
|
4
Total Companies2008
Oldest Founded4
Countries85
Unique SkillsSimilar Companies
Other organizations in the same industry
CannaLean Biotechs
Biotechnology-ResearchAn R&D company developing CBD based solutions to benefit millions of patients suffering from Dyslipi...
Nanocan Therapeutics Corporation
Biotechnology-ResearchAn early stage biotechnology company developing nanotechnology based therapeutic medicines to treat...
Good Cells
Biotechnology-ResearchGOOD CELLS is a Ukrainian innovative medical company with a high-capacity biotechnology laboratory,...
Ikonisys
Biotechnology-ResearchFinding the cells that matter
Alternative Company Names
This company is also known as